Status:
RECRUITING
Gaucher Disease Outcome Survey (GOS)
Lead Sponsor:
Shire
Conditions:
Gaucher Disease
Eligibility:
All Genders
Brief Summary
The Gaucher Outcomes Survey (GOS) is an ongoing observational, international, multi-center, long-term Registry of Patients with Gaucher Disease irrespective of their treatment status or type of treatm...
Detailed Description
20 MAY 2020: The temporary enrollment stop of new patients into this study due to the COVID-10 pandemic has been lifted in one or more countries/sites, and the study is now again enrolling new patient...
Eligibility Criteria
Inclusion
- Patients of any age or gender with confirmed diagnosis (biochemical and/or genetic) of Gaucher disease
- Signed and dated written informed consent from the patient or, for patients aged \<18 years (\<16 years in the United Kingdom \[UK\]), their parent and/or legally authorized representatives (LAR), and assent of the minor where applicable. Legally authorized representatives are also applicable for cognitively impaired patients.
Exclusion
- \- Patients currently enrolled in ongoing blinded clinical trials (drugs or devices; includes all blinded trials)
Key Trial Info
Start Date :
July 27 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
1257 Patients enrolled
Trial Details
Trial ID
NCT03291223
Start Date
July 27 2010
End Date
September 30 2026
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Contact
Lexington, Massachusetts, United States, 02421